Linda Cremonesi

Linda Cremonesi

Dip. Scienze Chirurgiche, University of Verona, Verona, Veneto, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
ADAlessia Dallatana
Alessia Dallatana
LCLinda Cremonesi
Linda Cremonesi
MTMaddalena Trombetta
Maddalena Trombetta
Giulio FracassoGiulio Fracasso
Giulio Fracasso
Riccardo NociniRiccardo Nocini
Riccardo Nocini
Giulio InnamoratiGiulio Innamorati
Giulio Innamorati
The human genome counts hundreds of GPCRs specialized to sense thousands of different extracellular cues, including light, odorants and nutrients in addition to hormones. Primordial GPCRs were likely glucose transporters that became sensors to monitor the abundance of nutrients and direct the cell to switch from aerobic metabolism to fermentation. Human β cells express multiple GPCRs that contribute to regulate glucose homeostasis, cooperating with many others expressed by a variety of cell types and tissues. These GPCRs are intensely studied as pharmacological targets to treat type 2 diabetes in adults. The dramatic rise of type 2 diabetes incidence in pediatric age is likely correlated to the rapidly evolving lifestyle of children and adolescents of the new century. Current pharmacological treatments are based on therapies designed for adults, while youth and puberty are characterized by a different hormonal balance related to glucose metabolism. This review focuses on GPCRs functional traits that are relevant for β cells function, with an emphasis on aspects that could help to differentiate new treatments specifically addressed to young type 2 diabetes patients.